Connect with us

Politics

Medical Marijuana Group Urges Governors To Protect Patient Access Amid Coronavirus Outbreak

Published

on

As state and local governments across the U.S. shutter businesses and prohibit gatherings in an attempt to limit the spread of the COVID-19 pandemic, medical marijuana patients and advocates are urging policymakers not to close down cannabis dispensaries completely.

Such a move, they warn, would leave hundreds of thousands of patients stranded without access to medicine, and many would have no choice but to turn to the illicit market.

In an “emergency call to action” sent Monday to governors of legal medical marijuana states, Americans for Safe Access, a leading nonprofit medical cannabis advocacy group, asked the officials to take immediate steps to ensure that patients have access to products during a period of social distancing that has no clear end in sight.

The letter came the same day that San Francisco’s Department of Public Health ordered all dispensaries in the city closed, announcing that both storefront dispensaries and delivery services “are not considered an ‘essential business’” and will need to close as of Tuesday.

Other jurisdictions are taking more proactive approaches to meeting patient needs. In Pennsylvania, dispensaries are expected to remain open because they fall into the same classification as pharmacies. In Michigan and Illinois, officials have temporarily allowed curbside pickups at cannabis retail stores in order to allow medical patients and consumers access to marijuana while limiting the spread of the virus from person to person.

In its letter to governors, ASA recommends that policymakers take steps now to protect cannabis patients and ensure they have access to medical marijuana in coming months. It lists eight measures to put into place “immediately to ensure that patients do not have disrupted access to their medicine”:

  1. Make sure that cannabis businesses that serve patients are considered “essential” businesses.
  2. Instruct medical cannabis businesses on how they can make legal temporary changes to their business plans, including delivery and purchase limits, to accommodate patients and staff during the crisis.
  3. Give tax relief to patients and businesses.
  4. Allow cultivation and processing centers to stay open to ensure a steady supply of medicine in the future.
  5. Extend the expiration dates of state-issued cannabis identification cards so that doctors and other health care providers can focus on COVID-19.
  6. Permit authorized caregivers to serve additional patients during the crisis period.
  7. Allow telehealth visits for new and renewing medical cannabis patients.
  8. Allow dispensaries to deliver medical cannabis to qualifying patients and caregivers in vehicles parked in the dispensary parking lots.

ASA is also asking concerned citizens to write to their governors, insisting that patient access to cannabis be protected during the pandemic.

Medical marijuana patients “represent some of the states’ most vulnerable citizens,” ASA interim Director Debbie Churgai said in the letter. “We are calling on states to take precautions now to help ensure that patients have access today and that measures are taken to ensure that the supply chain is not interrupted.”

As officials scramble to determine which businesses can remain open during the outbreak, jurisdictions so far have taken a variety of approaches to marijuana availability, for both patients and adult non-medical consumers. In Massachusetts, medical dispensaries “have been advised they may consider the promotion and geographic expansion of delivery service,” the state Cannabis Control Commission said in a release last week, “and to remind patients of the ability to acquire up to a 60-day medical grade marijuana supply.

Dispensaries are to remain open in Puerto Rico, too, where the Department of Health announced on Monday that the medical cannabis industry will be excluded from the governor’s recent mandatory shutdown order there.

Parts of Colorado are also allowing dispensaries to stay open. Summit County, for example, will allow cannabis retailers to remain open, along with liquor stores, gas stations, banks, grocery stores and pharmacies.

And in the Netherlands, the country’s iconic coffeeshops are staying open, but they’re no longer social destinations. For the foreseeable future, only to-go sales are allowed.

In other areas such as Washington State, individual businesses have adopted policies designed to limit interaction between visitors and avoid spreading coronavirus. Lines have begun to grow on sidewalks as stores restrict the number of people inside at one time. To help speed transactions, businesses are asking customers to place orders in advance through online menus.

Complicating the social-distancing effort is the fact that delivery services remain illegal in the state for both medical and adult-use marijuana, forcing patients and customers to show up in person. Home cultivation is allowed only for state-licensed medical patients.

Other cannabis-related efforts have seen obstacles as COVID-19 spreads through the country.

In California, organizers behind a proposed ballot initiative to expand cannabis access (including filmmaker Kevin Smith and actor Jason Mewes of “Jay and Silent Bob” fame) have asked officials to let them seek signatures online rather than in person.

In Washington, D.C., organizers also want to be able to collect signatures online for a measure that would decriminalize certain psychedelics. And throughout the country, uncertainty and fears of prolonged quarantines have led patients and consumers to flock to retail outlets.

Filmmaker Kevin Smith Requests Digital Signatures For Marijuana Initiative Due To Coronavirus

Photo by Aphiwat Chuangchoem

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Ben Adlin is a Seattle-based writer and editor. He has covered cannabis as a journalist since 2011, most recently as a senior news editor for Leafly.

Politics

The White House Is Reviewing CBD And Marijuana Research Guidance From FDA

Published

on

The White House is currently reviewing a federal plan for marijuana and CBD research.

The Food and Drug Administration (FDA) submitted draft guidance on the issue last week to the White House Office of Management and Budget (OMB).

Details about the document—titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research”—are sparse. But an FDA spokesperson indicated to Marijuana Moment that it’s related to the agency’s ongoing work to develop broader CBD regulations that could eventually allow for the marketing of cannabis products as dietary supplements or food items.

“We recognize that there is substantial public interest in marketing and accessing CBD for a variety of products. We are working toward a goal of providing additional guidance, and have made substantial progress,” FDA said in a statement. “There are many questions to explore regarding the science, safety, effectiveness and quality of products containing CBD, and we need to do our due diligence.”

“As part of our work, the FDA continues to explore potential pathways for various types of CBD products to be lawfully marketed,” the statement continues. “An important component of this work is obtaining and evaluating information to address outstanding questions related to the safety of CBD products that will inform our consideration of potential regulatory frameworks for CBD while maintaining the FDA’s rigorous public health standards.”

What remains to be seen is whether FDA plans to wait for this specific guidance to be finalized and for the resulting research to be completed before it gets around to issuing final rules for CBD products in general. Stakeholders have been eagerly awaiting those regulations so they can fully take advantage of the legalization of hemp and its derivatives.

“We will continue to update the public about our path forward as our work progresses, and provide information that is based on sound science and data,” FDA said.

While sending the guidance to OMB could be interpreted as a positive development signaling that FDA is making progress on the development of regulations, former FDA Commissioner Scott Gottlieb said on Saturday that White House policies requiring OMB to review scientific documents in the first place represent an onerous step that’s delayed the issuance of guidance.

The FDA spokesperson declined to comment on the former commissioner’s statement.

The agency first announced in January that it planned to publish guidance on cannabis research this year. It’s not clear how long the OMB review will take or when the document will be finalized for public release.

In addition to sending the guidance to the White House for review, FDA is also soliciting public input about the safety and efficacy of CBD in comment period it has decided to keep open indefinitely. The agency said in an update to Congress in March that it has several specific questions it wants answered before deciding whether the cannabidiol can be lawfully marketed. That includes questions about the impact of different methods of consumption and drug interactions.

In the meantime, FDA is maintaining enforcement discretion when it comes to action against companies that sell CBD products regardless of the lack of regulations and has said it is currently targeting sellers that make especially outlandish or unsanctioned claims about the therapeutic value of their products.

It sent a warning letter to a CBD company owned by a former NFL player after advertisements it displayed suggested its products could treat and prevent a coronavirus infection, for example.

FDA sent a letter warning to a company about its marketing of injectable CBD products that led to a voluntary recall last month.

The agency also publicized a voluntary recall of another CBD product from a different company, notifying consumers about potentially high levels of lead in a batch of tinctures.

FDA has previously issued warnings to other CBD companies that have made unsubstantiated claims about the therapeutic potential of their products.

Scientists And Veterans File Lawsuit Challenging DEA’s Marijuana Rescheduling Denials

Photo by Kimzy Nanney.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Marijuana Legalization And The Fight For Racial Justice (Op-Ed)

Published

on

“Black and brown lives matter and we owe it to our country and to ourselves to take tangible steps toward dismantling many of the power structures that perpetuate injustice. Marijuana prohibition is simply one of them.”

By Erik Altieri, NORML

On May 25th, George Floyd was killed on camera by officers affiliated with the Minneapolis Police Department. As were many Americans, we were shocked and disheartened by this tragic and needless loss of life.

As the events of the past few days have unfolded, it is clear that America is in the midst of a long overdue reckoning with itself. Since 1619, when the first ships arrived on the coast of Virginia with enslaved Africans in chains, our country has long had to struggle to address the inequality and structural racism embedded within our public institutions—particularly within the criminal justice system.

From slavery and the Civil War, to the battles to end Jim Crow laws, to the marches for civil rights, to the protests against mass incarceration, to the Black Lives Matter movement, each generation of Americans has stepped up to take action to fight to end racial injustice.

As protests continue to take place across our nation, more Americans are beginning to publicly demand action from their local, state and federal leaders to end the policies and practices that promote, enable and drive systemic racial injustice. In these conversations about policy solutions, many will include in their demands an ending to the war on drugs—or, at a minimum, an ending to marijuana criminalization. But while ending cannabis prohibition is both important and necessary, we must also recognize that doing so is but a single piece of a much larger puzzle.

Will legalizing marijuana reform alone solve the problem of racial injustice? No.

Is ending cannabis prohibition going to fix all of America’s social ills? No.

After we legalize adult-cannabis use, will we see an end to discriminatory policing against communities of color and other marginalized groups? No.

Will end marijuana prohibition be a small step toward the greater goal of promoting justice? Without a doubt, yes.

And the majority of Americans agree.

Our decades-long prohibition of marijuana was founded upon racism and bigotry. Look no further than the sentiments of its architect, Harry J. Anslinger, Commissioner of the Federal Bureau of Narcotics, who declared: “[M]ost [marijuana consumers in the US] are Negroes, Hispanics, Filipinos and entertainers. … [M]arijuana causes white women to seek sexual relations with Negroes. … Reefer makes darkies think they’re as good as white men.”

These racial biases were later exploited by the Nixon administration when it ramped up the drug war in 1970 and declared cannabis to be “public enemy #1.” As former Nixon adviser John Ehrlichman later acknowledged: “The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and black people. You understand what I’m saying? We knew we couldn’t make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.”

Today, the modern era of marijuana prohibition continues to be disproportionately applied. Annually, over 650,000 Americans are arrested for violating marijuana laws. Yet, according to an analysis of these arrests released earlier this year by the ACLU, “In every single state, Black people were more likely to be arrested for marijuana possession, and in some states, Black people were up to six, eight, or almost ten times more likely to be arrested. In 31 states, racial disparities were actually larger in 2018 than they were in 2010.”

Of course, marijuana prohibition isn’t the sole cause of America’s racial inequities, nor is it the sole reason why certain members of the police continue to engage in racially-aggressive policing and misconduct. But its criminalization is one of the tools commonly used to justify and perpetuate these injustices.

For example, marijuana enforcement was the pretext in the fatal law enforcement shooting of another Minnesotan just a few years before George Floyd’s murder: Philando Castile. The officer in this case alleged that he feared for his life simply because he believed that Mr. Castille had been smoking marijuana, stating: “I thought I was gonna die. And I thought if he’s, if he has the guts and the audacity to smoke marijuana in front of the 5-year-old girl and risk her lungs and risk her life by giving her secondhand smoke and the front seat passenger doing the same thing then what, what care does he give about me. And, I let off the rounds and then after the rounds were off, the little girl was screaming.”

Even in those jurisdictions where adult-use cannabis is legal, we know that there still remains much work to be done to address continuing racial inequities. For instance, African Americans and Latinos continue to disproportionately be targeted for traffic stops in Colorado and Washington even after legalization.

Then there is the question of the cannabis industry itself. We advocates need to continue to push for inclusion and equity within this space. We must not ignore the reality that while a handful of venture capitalists are now engaging in licensed cannabis sales in systems that largely exclude minority ownership while millions of others—most of them young, poor and people of color—continue to face arrest and incarceration for engaging in much of the same behavior.

There is no doubt that our national discussion over matters of race and policing will continue long after these public protests have ceased. NORML believes that calls for cannabis legalization need to be an important part of this emerging discussion—but only a part. Black and brown lives matter and we owe it to our country and to ourselves to take tangible steps toward dismantling many of the power structures that perpetuate injustice. Marijuana prohibition is simply one of them.

We are at a crossroads in this country and it is time for all of us to march as allies in the fight for racial justice and equality. It is important during this process for those of us not from these marginalized communities to truly listen to those who are facing this oppression and support them in this struggle. Let us take this moment in time to pledge to put in the work necessary in order to make America the better and more just nation that we know it can be.

Erik Altieri is executive director of NORML.

Cory Booker Cites Marijuana Enforcement As Example Of Racial Injustice That Is Motivating Protests

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Two-Thirds Of Arizona Voters Support Marijuana Legalization Ballot Measure, Poll Shows

Published

on

If Arizona marijuana activists succeed in placing a legalization initiative before voters this November, it will likely pass by a wide margin, according to a new poll.

In a survey of likely voters, about two-thirds (65.5 percent) of respondents said they would support the proposed measure, the Smart and Safe Arizona Act. That’s a notable shift since residents were surveyed late last year in a poll that showed 54 percent in favor of the policy change.

The survey described the legalization initiative, which would make it legal for adults 21 and older to purchase and possess cannabis and also impose taxes on legal sales, and asked 400 respondents if they would vote yes or no on the proposal

Forty-seven percent said they would “definitely” back it and 18.5 percent said they “probably” would. Nineteen percent said they “definitely” would not vote for it, while six percent said they “probably” wouldn’t.

The campaign behind the initiative, Smart and Safe Arizona, said in April that it had collected enough raw signatures to qualify for the ballot. However, those haven’t been verified by the state yet and the group said it plans to continue petitioning to ensure success. Stacy Pearson, campaign manager for the organization, told Marijuana Moment on Tuesday that they’re “on track to turn in more than 400,000 signatures by the July 2 deadline.”

“The HighGround poll is encouraging and tracks with what our internal polling shows—Arizonans are ready to legalize marijuana,” she said. “Particularly in this economic environment, new jobs and tax revenue are important to voters.”

Activists asked the state Supreme Court to allow electronic signature gathering given challenges presented by the coronavirus pandemic, but that request was rejected.

In the poll, which was conducted from May 18-22, the only group that appears divided on the issue are those who identify as “very conservative.” They were evenly split—47.6-47.6 percent—on whether or not they’d vote in favor of legalization. All other demographics were solidly in favor of the proposal.

Via Higherground.

“As long as Smart and Safe Arizona can qualify for the ballot, all signs point to 2020 being the year that recreational marijuana finally becomes legal in Arizona,” Paul Bentz, senior vice president of research and strategy at HighGround, said in a press release. “Of course, there is still strong opposition among some of those who represent the most conservative segments of the electorate. We should expect a legal challenge coming from that audience because at this point, that’s the likely the only way they can defeat this issue.”

Under the measure, adults could possess up to an ounce of marijuana at a time and cultivate up to six plants for personal use.

The initiative also contains several restorative justice provisions such as allowing individuals with prior marijuana convictions to petition the courts for expungements and establishing a social equity ownership program

Cannabis sales would be taxed at 16 percent. Tax revenue would cover implementation costs and then would be divided among funds for community colleges, infrastructure, a justice reinvestment and public services such as police and firefighters.

The Department of Health Services would be responsible for regulating the program and issuing cannabis business licenses. It would also be tasked with deciding on whether to expand the program to allow for delivery services.

A 2016 legalization proposal was rejected by Arizona voters. But in the four years since, more states have opted to legalize and public opinion has continued to shift in favor of reform.

“Clearly, the initiative backers have learned from the mistakes of the past and have done everything they can to put together a more palatable proposal,” Bentz said. “In particular, they were wise to make this proposition more ‘family friendly’ by banning smoking in public and ensuring products cannot resemble children’s candy. Ultimately, that’s likely what got them over the hump with a majority of Republicans.”

Michigan Bill To Let Elected Officials’ Spouses Obtain Marijuana Licenses Advances While Equity Issues Persist

Photo courtesy of Brian Shamblen.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!